| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.9 |